Investing.com - Mizuho initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with an outperform rating and set a price target of $26.00. The target represents nearly 90% upside from the current ...

Investing.com - JPMorgan initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with an Overweight rating and set a price target of $29.00, analyst Brian Cheng said Monday. The target represents ...

Investing.com -- Eikon Therapeutics Inc. (NASDAQ:EIKN) shares fell 5.7% following Wedbush analyst Robert Driscoll’s initiation of coverage with an Underperform rating and a $7.00 price target. The ...

Eikon Therapeutics, Inc. (Nasdaq: EIKN), a California-based, late-stage biotechnology company, visits the Nasdaq MarketSite in Times Square. Eikon is led by executive and clinical teams behind the ...

Biotechnology companies going public this week are signaling a resurgence for initial public offerings and venture-capital investment in the sector this year. Biotechs Eikon Therapeutics and ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eikon Therapeutics increased the ...

Eikon Therapeutics shares were down 6%, at $16.90, in the stock's first day of trade on the Nasdaq Global Select Market. Shares of the clinical-stage biopharmaceutical company began trading midday ...

Despite progress made in cancer immunotherapy, some patients don’t respond to these treatments or they stop responding after a period of time. Eikon Therapeutics’ lead drug candidate could address ...

Feb ‌5 (Reuters) - Drug developer Eikon Therapeutics, headed ‌by Merck veteran Roger Perlmutter, was valued at about $860.3 million after its shares opened 5.3% below their offer price in their Nasdaq ...

Eikon Therapeutics raised an upsized US$381m late Wednesday from its Nasdaq IPO that included participation by Merck, a banker involved in the offering told IFR. The banks were multiple times ...

These are the ceremonies for February 2026. Market opening and closing ceremonies take place on weekdays at the Nasdaq MarketSite Studio in Times Square and around the globe. Eikon Therapeutics, Inc. ...